September 29, 2016 11:19 AM ET

Life Sciences Tools and Services

Company Overview of NuGEN Technologies, Inc.

Company Overview

NuGEN Technologies, Inc. develops and commercializes technologies and products for accurate and targeted genomic analysis. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. It provides a portfolio of technologies to address microarray and Next-Gen Sequencing applications, including RNA-Seq, targeted resequencing of DNA and RNA, target capture, ChIP-Seq, and Methyl-Seq; sample preparation solutions for RNA and DNA that enable the analysis of specimens, which are limited or of poor quality on microarray and qPCR analysis platforms; and sample preparation solutions for high throughput applications, such as Next Gen Sequencing, microarray...

201 Industrial Road

Suite 310

San Carlos, CA 94070

United States

Founded in 2000

Phone:

650-590-3600

Fax:

650-590-3630

Key Executives for NuGEN Technologies, Inc.

Chief Executive Officer
Chief Financial Officer
Senior Director of Product Marketing
Director of Technical Support
Director of Sales - Asia Pacific
Compensation as of Fiscal Year 2016.

NuGEN Technologies, Inc. Key Developments

NuGEN Technologies, Inc. Announces Launch of Fusion Data Analysis Application, Enabling Simplified Fusion Detection and Discovery

NuGEN Technologies, Inc. announced the availability of the Ovation Fusion Detection application, providing a data analysis tool for the Ovation Fusion Target Enrichment System V2 that enables a complete sample-to-analysis workflow for fusion discovery and detection. The Ovation Fusion Panel Target Enrichment System V2 allows the comprehensive interrogation of multiple, specific genes for RNA sequencing, significantly simplifying fusion detection when compared with standard RNA sequencing approaches. Sequence data generated from this targeted enrichment technology can then be analyzed using the application on the BaseSpace cloud or as a local Linux installation. Structural chromosome rearrangements resulting in fusion genes are implicated in all types of human cancer, making the discovery and detection of these fusions valuable for both diagnostic and prognostic purposes. NuGEN’s products offer rapid and simple workflows for a broad range of next generation DNA and RNA sequencing applications, enabling highly sensitive detection of variants and expression levels from tissues, single cells and liquid biopsies. NuGEN’s products are used by thousands of scientists worldwide and have been cited in over 2,000 peer-reviewed publications.

NuGEN Technologies, Inc. Announces Management Changes

NuGEN Technologies, Inc. announced the appointment of Nitin Sood as Chief Executive Officer. He succeeds Elizabeth Hutt who recently left to pursue another opportunity. Mr. Sood comes to NuGEN from PerkinElmer, where he served as Vice President and General Manager of their life science instruments business spanning a portfolio of products in imaging, detection, tissue pathology, automation and NGS sample prep. Prior to his current role, Mr. Sood was the Chief Executive Officer of Boreal Genomics.

NuGEN Technologies, Inc. Announces Commercial Introduction of Ovation SoLo RNA-Seq System

NuGEN Technologies, Inc. announced the launch of the Ovation SoLo RNA-Seq System, the company’s latest tool in its suite of sample preparation products supporting research in areas previously hampered by sample input limitations such as single cells and liquid biopsy. The Ovation SoLo kit will facilitate research in areas such as blood-borne biomarkers, cellular heterogeneity, and the study of single cell transcriptomics. Ovation SoLo provides a complete end-to-end solution for whole transcriptome analyses starting directly from cells or isolated RNA. The result is the most comprehensive cellular data and the best biology from the broadest range of input levels in samples with limited RNA quantity including single cell, liquid biopsy, and other low input RNA samples. The system features an improved method for ribosomal depletion of > 90%, efficient cDNA generation from ultra-low inputs that provides a complete representation of the entire transcriptome, and the capability to unambiguously identify PCR duplicates.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NuGEN Technologies, Inc., please visit www.nugen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.